Intraoperative neuromonitoring company Assure Holdings hired two executives.
Spinal Tech
From new acquisitions to new leadership, here are seven developments from Medtronic in the first quarter of 2022:
Changes are afoot in the orthopedic device industry, as several medtech companies have appointed new CEOs in 2022.
The compensation of medtech leaders varies based on the company's size and market share. While some have a larger base salary, others have higher bonuses and stock option value.
In the last week, two devicemakers have been named in spine and orthopedic lawsuits.
Advertisement
Since March 4, six spine and orthopedic devicemakers announced leadership moves.
The FDA granted 16 orthopedic device approvals in February:
Spine and orthopedic medtech companies are drawing the eyes and dollars of investors in 2022. Five companies have netted a total $123.6 million in deals so far.
Augmedics, developer of the Xvision augmented reality spine surgery system, began 2022 with a new CEO and recently added former Medtronic and Johnson & Johnson executives to its leadership team to help take the company to the next level.
Surgalign Holdings' global revenue for the fourth quarter decreased 16.8 percent year over year to $21.8 million as COVID-19 headwinds such as hospital staff shortages and procedural restrictions continued to affect surgical specialties.